This inventor holds 1 USPTO granted patent. Top assignee: Leibniz-Institut Fur Analytische Wissenschaften - Isas - E.v.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Dominik Megger: Innovator in Biomarker Research
Introduction
Dominik Megger is a prominent inventor based in Dortmund, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the identification of biomarkers for cholangiocellular carcinoma (CCC). His innovative work aims to enhance the diagnosis, surveillance, and treatment of this challenging cancer.
Latest Patents
Dominik Megger holds a patent related to biomarkers for cholangiocellular carcinoma. The patent describes a method for identifying specific marker proteins that serve as biomarkers for CCC. This invention not only identifies these biomarkers but also outlines their use in diagnostics and treatment. Furthermore, it includes a diagnostic device that utilizes these biomarkers in a screening assay to identify novel pharmaceutical compounds for the treatment of CCC. He has 1 patent to his name.
Career Highlights
Dominik Megger is affiliated with the Leibniz Institute for Analytical Sciences (ISAS) in Germany. His work at this esteemed institution has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in cancer diagnostics.
Collaborations
Some of his notable coworkers include Helmut E. Meyer and Thilo Bracht. Their collaboration has further advanced the research and development of innovative diagnostic methods for cholangiocellular carcinoma.
Conclusion
Dominik Megger's contributions to the field of biomarker research are invaluable. His work not only aids in the early detection of cholangiocellular carcinoma but also paves the way for new treatment options. His innovative spirit and dedication to improving cancer diagnostics continue to inspire advancements in medical science.